These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33691908)

  • 41. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
    Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
    Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An HP1 isoform-specific feedback mechanism regulates Suv39h1 activity under stress conditions.
    Raurell-Vila H; Bosch-Presegue L; Gonzalez J; Kane-Goldsmith N; Casal C; Brown JP; Marazuela-Duque A; Singh PB; Serrano L; Vaquero A
    Epigenetics; 2017 Feb; 12(2):166-175. PubMed ID: 28059589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
    Cattaneo F; Nucifora G
    J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
    Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
    Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation.
    Akinmade D; Lee M; Zhang Y; Hamburger AW
    Int J Oncol; 2007 Oct; 31(4):851-8. PubMed ID: 17786317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo.
    Chakraborty S; Sinha KK; Senyuk V; Nucifora G
    Oncogene; 2003 Aug; 22(34):5229-37. PubMed ID: 12917624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.
    Lu Y; Zhou H; Chen W; Zhang Y; Hamburger AW
    Breast Cancer Res Treat; 2011 Feb; 126(1):27-36. PubMed ID: 20379846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.
    Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM
    Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.
    Mal AK
    EMBO J; 2006 Jul; 25(14):3323-34. PubMed ID: 16858404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.
    Ghosh A; Awasthi S; Hamburger AW
    Oncol Rep; 2013 Mar; 29(3):1161-6. PubMed ID: 23242156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells.
    Bandyopadhyay S; Montagna C; Macian F
    Eur J Immunol; 2012 Sep; 42(9):2471-83. PubMed ID: 22684523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of EZH2, SUV39H1, G9a and associated molecules in pathogenesis of urethane induced mouse lung tumors: potential targets for cancer control.
    Pandey M; Sahay S; Tiwari P; Upadhyay DS; Sultana S; Gupta KP
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):296-304. PubMed ID: 25168426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Class II transactivator (CIITA) mediates IFN-γ induced eNOS repression by enlisting SUV39H1.
    Weng X; Zhang Y; Li Z; Yu L; Xu F; Fang M; Hou L; Ge J; Xu Y
    Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):163-172. PubMed ID: 30716531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Over-expression of the SUV39H1 histone methyltransferase induces altered proliferation and differentiation in transgenic mice.
    Czvitkovich S; Sauer S; Peters AH; Deiner E; Wolf A; Laible G; Opravil S; Beug H; Jenuwein T
    Mech Dev; 2001 Sep; 107(1-2):141-53. PubMed ID: 11520670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The histone methyltransferase Suv39h regulates 3T3-L1 adipogenesis.
    Jing J; Li F; Zha L; Yang X; Wu R; Wang S; Xue B; Shi H
    Adipocyte; 2020 Dec; 9(1):401-414. PubMed ID: 32698678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.
    Sewalt RG; Lachner M; Vargas M; Hamer KM; den Blaauwen JL; Hendrix T; Melcher M; Schweizer D; Jenuwein T; Otte AP
    Mol Cell Biol; 2002 Aug; 22(15):5539-53. PubMed ID: 12101246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suv39h1 promotes facet joint chondrocyte proliferation by targeting miR-15a/Bcl2 in idiopathic scoliosis patients.
    Li J; Yang G; Liu S; Wang L; Liang Z; Zhang H
    Clin Epigenetics; 2019 Jul; 11(1):107. PubMed ID: 31337422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered telomere homeostasis and resistance to skin carcinogenesis in Suv39h1 transgenic mice.
    Petti E; Jordi F; Buemi V; Dinami R; Benetti R; Blasco MA; Schoeftner S
    Cell Cycle; 2015; 14(9):1438-46. PubMed ID: 25789788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.